NTRA — Natera, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1604821 ·
Last close
$234.76
Market Cap
$33.62B
52W High
$240.72
52W Low
$181.00
ADV30
1,486,127
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 696,644,000 | 450,833,000 | -93,516,000 | -85,091,000 | 2,614,398,000 | 1,087,932,000 | 840,380,000 |
| Dec 2025 | 665,498,000 | 445,427,000 | -22,785,000 | 47,258,000 | 2,398,344,000 | 1,076,140,000 | 685,931,000 |
| Sep 2025 | 592,183,000 | 384,382,000 | -97,576,000 | -87,544,000 | 1,821,482,000 | 1,041,438,000 | 569,294,000 |
| Jun 2025 | 546,600,000 | 346,604,000 | -110,372,000 | -100,938,000 | 1,757,066,000 | 1,000,021,000 | 510,884,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$211,020,000
Investing CF
$-147,531,000
Financing CF
$50,675,000
CapEx
$-139,510,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.48
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,861,113,000
Inventory
$70,721,000
Receivables
$417,595,000
ST Investments
—
EBIT TTM
$-282,177,000
Pretax Income TTM
$-286,134,000
Interest Exp TTM
$3,957,000
Analysts
18
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,500,926,976
EBITDA
$-267,576,992
Free Cash Flow
$136,918,256
Enterprise Value
$32,773,392,384
Total Cash
$1,087,932,032
Total Debt
$240,080,992
Shares Out
143,215,382
Trailing EPS
$-1.62
Book Value
$12.43
ROE
-15.0%
ROA
-9.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,306,113,000 | -309,911,000 | -208,160,000 | 2,398,344,000 | 685,931,000 | — | 215,301,000 |
| Dec 2024 | 1,696,911,000 | -222,294,000 | -190,426,000 | 1,660,735,000 | 465,315,000 | — | 135,664,000 |
| Dec 2023 | 1,082,571,000 | -446,245,000 | -434,801,000 | 1,441,699,000 | 676,372,000 | — | -246,955,000 |
| Dec 2022 | 820,222,000 | -541,040,000 | -547,799,000 | 1,394,474,000 | 688,730,000 | — | -431,501,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.21
Max Pain — expiry 2026-07-17
max pain strike: $220.00 · spot: $262.45 · call oi: 4,832 · put oi: 1,552
Expected Move to 2026-07-17:
±$75.50
(28.77%) —
implied range
$186.95 –
$337.95
· ATM straddle on $260.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DGX | QUEST DIAGNOSTICS INC | $21.83B | $197.18 | — |
| LH | LABCORP HOLDINGS INC. | $21.20B | $258.59 | — |
| GH | Guardant Health, Inc. | $17.35B | $130.83 | — |
| THC | TENET HEALTHCARE CORP | $15.58B | $180.88 | — |
| DVA | DAVITA INC. | $13.54B | $210.93 | — |
News headlines (Yahoo Finance, 1h cache)
Natera Flashes A Buy Signal. Why Shares Just Leaped By Double Digits.
2026-06-24 16:48 · Yahoo
Why Natera (NTRA) Is Up 6.7% After Japan Approves First MRD Test for Colorectal Cancer
2026-06-24 10:13 · Yahoo
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
2026-06-24 09:00 · Yahoo
Natera (NTRA) Teams With Pirche To Link Transplant Risk And Prospera Monitoring
2026-06-24 08:09 · Yahoo
Natera (NTRA) Stock Fair Value Edges Lower As MRD And Signatera Debate Splits Analysts
2026-06-23 18:16 · Yahoo
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as AI Spending Concerns Weigh on Technology Shares
2026-06-23 13:19 · Yahoo
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update
2026-06-23 10:00 · Yahoo
Pirche Announces Partnership to Advance Transplant Medicine by Combining Pre-Transplant Risk Stratification and Post-Transplant dd-cfDNA Monitoring
2026-06-19 19:06 · Yahoo
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress
2026-06-18 10:00 · Yahoo
Natera (NTRA), CytoDyn Announce Strategic Collaboration for ctDNA-Guided mCRC Clinical Trials
2026-06-17 13:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.